Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period
Conference abstract
[키워드] 95% confidence interval
addition
Affect
age
Analysis
Anemia
anemic
Anxiety
baseline
baseline characteristics
blueprint
board
cancer diagnosis
change
changes in
clinical
clinical feature
Clinical outcome
Cohort
Community
comparable
competing
concerning
conducted
COVID
COVID-19
COVID-19 pandemic
Cox proportional hazard
Cyclophosphamide
database
death
Delayed
determine
diagnosed
Diagnosis
download
equity
evaluated
Evidence
examined
family member
figure
Follow-up
funding
hospital
in-person visit
initial
ISS
Kaplan-Meier curve
Kidney disease
kidney dysfunction
Kidney function
log-rank test
mAb
management
measure
monoclonal antibody
Multiple
Multiple myeloma
Myeloma
no difference
North
not significant
notable
observé
pandemic
Patient
patients
pattern
Pearson
performance status
Period
receive
receiving
regimen
regimens
Regression model
risk
SAS
SAS Institute
Sex
Support
table
therapy
thyme
Travel
Treatment
treatment initiation
type I
variable
Version
was used
[DOI] 10.1182/blood-2021-148998 [Article Type] Conference abstract
[DOI] 10.1182/blood-2021-148998 [Article Type] Conference abstract